iPSc

Induced Pluripotent Stem cells (iPS) are genetically reprogrammed cells capable of dividing in culture with unlimited self-renewal. The emergence of these cells represents an opportunity to create a potentially unlimited cell source for differentiation into specialized cell types.
However, their amplification remains delicate. Current technologies can easily lead to premature cell differentiation, or damage them with excessive shear forces. This difficulty is partly responsible for the exorbitant costs of cell therapy. SoftCell Therapeutics offers a global solution to make the development of iPSc therapies easier and more affordable.